Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Green Cross Banking On Bioreactors To Develop Biosimilars, Biobetters Faster

This article was originally published in PharmAsia News

Executive Summary

SEOUL - Following a deal late last year to jointly develop biopharmaceutical products through disposable bioreactors, South Korea's vaccine giant Green Cross Corp. is expanding its collaboration to sell PBS Biotech, Inc.'s bioreactors to Korean companies
Advertisement

Related Content

Korea's Green Cross Files For Biobetter Of Shire's Hunter Syndrome Therapy Elaprase; Seeks Global Partners
Korea's Green Cross Files For Biobetter Of Shire's Hunter Syndrome Therapy Elaprase; Seeks Global Partners
Korea's Green Cross Strengthens Vaccine Supply Chain For Growing Export Demand
Korea's Green Cross Strengthens Vaccine Supply Chain For Growing Export Demand
Samsung Will Develop Biosimilars For U.S. And EU, But Avoids Emerging Markets For Now
Advertisement
UsernamePublicRestriction

Register

SC078607

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel